Application of a decision analytic framework for adoption of clinical trial results: Are the data regarding TARGIT-A IORT ready for prime time?

Breast Cancer Research and Treatment

Volumn 144, Issue 2, 2014, Pages 371-378

  Esserman, L J ^a   Alvarado, M D ^a   Howe, R J ^a   Mohan, A J ^b   Harrison, B ^a   Park, C ^a   O'Donoghue, C ^c   Ozanne, E M ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^d DARTMOUTH COLLEGE   (United States)

Author keywords

Clinical trials; Decision analysis; Local recurrence; Radiation

Indexed keywords

ARTICLE; CANCER RECURRENCE; CONCEPTUAL FRAMEWORK; DECISION TREE; EXTERNAL BEAM RADIOTHERAPY; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; INTRAOPERATIVE RADIOTHERAPY; LIFE EXPECTANCY; MEDICAL DECISION MAKING; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL (TOPIC); ADJUVANT THERAPY; AGED; ANIMAL; BREAST NEOPLASMS; CONTROLLED STUDY; DECISION SUPPORT SYSTEM; ECONOMICS; FEMALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PEROPERATIVE CARE; POSTMENOPAUSE; PROBABILITY; PROCEDURES; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANIMALS; BREAST NEOPLASMS; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; INTRAOPERATIVE CARE; MARKOV CHAINS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSTMENOPAUSE; QUALITY OF LIFE; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UNITED STATES;

EID: 84896542559     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-014-2881-2     Document Type: Article

References (26)

1. Giordano SH (2012) Radiotherapy in older women with low-risk breast cancer: why did practice not change? J Clin Oncol 30(14):1577-1578. doi:10.1200/JCO.2011.40.7007
2. Smith BD, Arthur DW, Buchholz TA et al (2009) Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 74(4):987-1001. doi:10.1016/j.ijrobp. 2009.02.031
3. Smith GL, Xu Y, Buchholz TA et al (2011) Brachytherapy for accelerated partial-breast irradiation: a rapidly emerging technology in breast cancer care. J Clin Oncol 29(2):157-165. doi:10.1200/JCO.2009.27.0942
4. Soulos PR, Yu JB, Roberts KB, et al (2012) Assessing the impact of a cooperative group trial on breast cancer care in the medicare population. J Clin Oncol 0(14):1601-1607. Available at: http://www.ncbi.nlm.nih.gov/pubmed/ 22393088. Accessed 7 Aug 2012
5. Hughes KS, Schnaper L a., Bellon JR, et al (2013) Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol. doi:10.1200/JCO.2012.45.2615
6. Fyles A, McCready D, Pintilie M, Shi W, Done S, Miller N, Olivotto I, Weir L, Liu F-F (2011) Luminal a subtype predicts radiation response in patients with T1N0 breast cancer enrolled in a randomized trial of tamoxifen with or without breast radiation. San Antonio Breast Cancer Symposium, San Antonio, TX
7. American College of Surgeons. Breast Cancer Measures. Available at: http://www.facs.org/cancer/ncdb/breastmeasures.pdf. Accessed 11 Oct 2012
8. Woloshin S, Schwartz LM (2006) What's the rush? The dissemination and adoption of preliminary research results. J Natl Cancer Inst 98(6):372-373. doi:10.1093/jnci/djj115
9. Vaidya JS, Joseph DJ, Tobias JS, et al (2010) Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase three trial. Lancet 376(9735):91-102. Available at: http://www.ncbi.nlm.nih.gov/ pubmed/20570343. Accessed 18 July 2011
10. Vaidya J, Wenz F, Bulsara M, et al (2012) Targeted intraoperative radiotherapy for early breast cancer: TARGIT-A trial-updated analysis of local recurrence and first analysis of survival. In: San Antonio Breast Cancer Symposium. San Antonio
11. Caro JJ, Briggs AH, Siebert U (2012) Modeling good research practices - overview : a report of the value in health. J Int Soc Pharmacoecon Outcomes Res 15:796-803
12. Weinstein MC, O'Brien B, Hornberger J, et al Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR task force on good research practices-modeling studies. Value in health. J Int Soc Pharmacoecon Outcomes Res 6(1):9-17. Available at: http://www.ncbi.nlm.nih. gov/pubmed/12535234. Accessed 16 July 2012
13. Alvarado MD, Mohan AJ, Esserman LJ, et al (2013) Cost-effectiveness analysis of intraoperative radiation therapy for early-stage breast cancer. Ann Surg Oncol 20:2873-2880
14. Cuzick J, Sestak I, Baum M et al (2010) Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. Lancet Oncol 11(12):1135-1141. doi:10.1016/S1470-2045(10) 70257-6
15. Darby S, McGale P, Correa C et al (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378(9804):1707-1716. doi:10.1016/S0140-6736(11)61629-2
16. Veronesi U, Orecchia R, Luini A et al (2010) Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons. Breast Cancer Res Treat 124(1):141-151. doi:10.1007/s10549-010-1115-5
17. Blamey RW, Bates T, Chetty U et al (2013) Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial. Eur J Cancer. doi:10.1016/j.ejca.2013.02.031
18. Haviland J, Agrawal R, Aird E, et al (2012) The UK START (Standardisation of Breast Radiotherapy) Trials: 10-Year follow-up results. In: San Antonio Breast Cancer Symposium. San Antonio
19. Whelan TJ, Pignol J-P, Levine MN, et al (2010) Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 362(6):513-520. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20147717. Accessed August 31, 2012
20. Esserman LJ, Shieh Y, Rutgers EJT et al (2011) Impact of mammographic screening on the detection of good and poor prognosis breast cancers. Breast Cancer Res Treat 130(3):725-734. doi:10.1007/s10549-011-1748-z
21. Esserman L, Shieh Y, Thompson I (2009) Rethinking screening for breast cancer and prostate cancer. JAMA, J Am Med Assoc 302(15):1685-1692. doi:10.1001/jama 2009.1498
22. Bleyer A, Welch HG (2012) Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 367(21):1998-2005. doi:10.1056/NEJMoa1206809
23. Fisher B, Montague E, Redmond C, et al (1980) Findings from NSABP Protocol No. B-04-comparison of radical mastectomy with alternative treatments for primary breast cancer. I. Radiation compliance and its relation to treatment outcome. Cancer 46(1):1-13. Available at: http://www.ncbi.nlm.nih.gov/pubmed/ 6992972. Accessed 18 Sep 2012
24. Buyse M, Loi S, van't Veer L, et al (2006) Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst 98(17):1183-1192. doi:10.1093/jnci/djj329 (Pubitemid 44390989)
25. Esserman LJ, Moore DH, Tsing PJ et al (2011) Biologic markers determine both the risk and the timing of recurrence in breast cancer. Breast Cancer Res Treat 129(2):607-616. doi:10.1007/s10549-011-1564-5
26. Fyles AW, McCready DR, Manchul L a, et al (2004) Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 351(10):963-970. doi:10.1056/NEJMoa040595